Trump Signs Order to Accelerate Ibogaine Research for Veterans

President Trump has signed an executive order aimed at fast-tracking research into ibogaine, a Schedule I psychedelic drug, for its potential use in treating PTSD, traumatic brain injury, depression, anxiety, suicidal ideation, and opioid addiction among veterans.